More than half of nursing home residents with advanced dementia continue to receive medications that may not help them, but incur substantial financial cost.
An analysis of more than 5,400 residents at 460 facilities (using 2009-2010 data) found nearly 54% of residents received at least one medication of questionable benefit.
The average 90-day expenditure for medications with questionable benefits was $816.
This accounts for 35.2% of the total average 90-day medication costs for residents with advanced dementia who were prescribed common medications with questionable benefits.
To learn more, see Tjia et al. (2014). Use of medications of questionable benefit in advanced dementia. JAMA Internal Medicine, 174(11), 1763-1771.